Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Adela Mazo
Human Pancreatic Cancer Stem Cells Are Sensitive to Dual Inhibition of IGF-IR and ErbB Receptors
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms
Clinical Cancer Research
Cancer Research
Oncology
Dual Inhibition of BMP and WNT Signals Promotes Pancreatic Differentiation From Human Pluripotent Stem Cells
Stem Cells International
Cell Biology
Molecular Biology
Human Microvascular Endothelial Cells Are Sensitive to IGF-I but Resistant to Insulin at the Receptor Level
Molecular and Cellular Endocrinology
Biochemistry
Endocrinology
Molecular Biology
Dual Inhibition of IGF-IR and ALK as an Effective Strategy to Eradicate NPM-ALK+ T-Cell Lymphoma
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Cancer Stem Cells in Pancreatic Cancer
Cancers
Cancer Research
Oncology
Targeting Pancreatic Cancer Stem Cells
Journal of Cancer Sciences
Lapatinib, a Dual Inhibitor of ErbB-1/-2 Receptors, Enhances Effects of Combination Chemotherapy in Bladder Cancer Cells
International Journal of Oncology
Cancer Research
Oncology
Pancreatic Cancer Spheres Are More Than Just Aggregates of Stem Marker-Positive Cells
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
